Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Prostate Cancer

  Free Subscription


Articles published in Radiology

Retrieve available abstracts of 47 articles:
HTML format



Single Articles


    July 2022
  1. LEE GH, Chatterjee A, Karademir I, Engelmann R, et al
    Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI.
    Radiology. 2022 Jul 26:211895. doi: 10.1148/radiol.211895.
    PubMed     Abstract available


  2. ZUKOTYNSKI KA, Kuo PH
    (18)F-DCFPyL PET/CT in Men with Prostate Cancer.
    Radiology. 2022 Jul 19:221536. doi: 10.1148/radiol.221536.
    PubMed    


  3. ULANER GA, Thomsen B, Bassett J, Torrey R, et al
    (18)F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation.
    Radiology. 2022 Jul 19:220218. doi: 10.1148/radiol.220218.
    PubMed     Abstract available


  4. GHAI S, Perlis N, Atallah C, Jokhu S, et al
    Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men.
    Radiology. 2022 Jul 19:212163. doi: 10.1148/radiol.212163.
    PubMed     Abstract available


    May 2022
  5. JADVAR H
    Prostate-specific Membrane Antigen PET: Standard Imaging in Prostate Cancer.
    Radiology. 2022 May 24:221074. doi: 10.1148/radiol.221074.
    PubMed    


  6. BASSO DIAS A, Finelli A, Bauman G, Veit-Haibach P, et al
    Impact of (18)F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer.
    Radiology. 2022 May 24:211836. doi: 10.1148/radiol.211836.
    PubMed     Abstract available


  7. HAIDER MA
    It's Time for a Standardized MRI Assessment Scheme for Prostate Cancer Recurrence.
    Radiology. 2022 May 10:220701. doi: 10.1148/radiol.220701.
    PubMed    


  8. PECORARO M, Turkbey BI, Purysko AS, Girometti R, et al
    Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score.
    Radiology. 2022 May 10:212252. doi: 10.1148/radiol.212252.
    PubMed     Abstract available


    March 2022
  9. WU D, Jiang K, Li H, Zhang Z, et al
    Time-Dependent Diffusion MRI for Quantitative Microstructural Mapping of Prostate Cancer.
    Radiology. 2022 Mar 8:211180. doi: 10.1148/radiol.211180.
    PubMed     Abstract available


  10. CHATTERJEE A, Oto A
    Prostate Tissue Microstructural Estimates Using Time-Dependent Diffusion MRI.
    Radiology. 2022 Mar 8:220056. doi: 10.1148/radiol.220056.
    PubMed    


    February 2022
  11. KUMAR R, Singh SK, Mittal BR, Vadi SK, et al
    Safety and Diagnostic Yield of (68)Ga Prostate-specific Membrane Antigen PET/CT Guided Robotic-assisted Transgluteal Prostatic Biopsy.
    Radiology. 2022 Feb 22:204066. doi: 10.1148/radiol.204066.
    PubMed     Abstract available


  12. UEDA T, Ohno Y, Yamamoto K, Murayama K, et al
    Deep Learning Reconstruction of Diffusion-weighted MRI Improves Image Quality for Prostatic Imaging.
    Radiology. 2022 Feb 1:204097. doi: 10.1148/radiol.204097.
    PubMed     Abstract available


    January 2022
  13. CIVELEK AC
    Management of Metastatic Prostate Cancer Biochemical Recurrence with Use of (18)F-DCFPyL PET/CT.
    Radiology. 2022 Jan 25:212993. doi: 10.1148/radiol.212993.
    PubMed    


  14. METSER U, Zukotynski K, Mak V, Langer D, et al
    Effect of (18)F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.
    Radiology. 2022 Jan 25:211824. doi: 10.1148/radiol.211824.
    PubMed     Abstract available


  15. RANASINGHE WKB, Troncoso P, Surasi DS, Ibarra Rovira JJ, et al
    Defining Diagnostic Criteria for Prostatic Ductal Adenocarcinoma at Multiparametric MRI.
    Radiology. 2022 Jan 25:204732. doi: 10.1148/radiol.204732.
    PubMed     Abstract available


  16. LAMBERG H, Shankar PR, Singh K, Caoili EM, et al
    Preoperative Prostate MRI Predictors of Urinary Continence Following Radical Prostatectomy.
    Radiology. 2022 Jan 18:210500. doi: 10.1148/radiol.210500.
    PubMed     Abstract available


  17. KANAS AF, Fenelon SS, Santos JMMM, Coelho RF, et al
    Case 297: Mucinous Adenocarcinoma of the Prostate.
    Radiology. 2022;302:238-242.
    PubMed     Abstract available


    December 2021
  18. GOTTLIEB RH
    Introducing a Standard in Prostate Cancer Imaging Evaluation.
    Radiology. 2021 Dec 21:212111. doi: 10.1148/radiol.212111.
    PubMed    


  19. WIBMER AG, Nikolovski I, Chaim J, Lakhman Y, et al
    Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes.
    Radiology. 2021 Dec 21:210875. doi: 10.1148/radiol.210875.
    PubMed     Abstract available


    November 2021
  20. CHATTERJEE A, Mercado C, Bourne RM, Yousuf A, et al
    Validation of Prostate Tissue Composition by Using Hybrid Multidimensional MRI: Correlation with Histologic Findings.
    Radiology. 2021 Nov 9:204459. doi: 10.1148/radiol.2021204459.
    PubMed     Abstract available


  21. WILLIAMS HT, Estes TL
    Anatomic and Functional Prostate Cancer Imaging.
    Radiology. 2021;301:E418.
    PubMed    


    October 2021
  22. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
    Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
    Radiology. 2021;301:E380.
    PubMed    


    August 2021
  23. WILLIAMS HT, Estes TL
    Anatomic and Functional Prostate Cancer Imaging.
    Radiology. 2021 Aug 31:211837. doi: 10.1148/radiol.2021211837.
    PubMed    


  24. MARGEL D, Bernstine H, Groshar D, Ber Y, et al
    Diagnostic Performance of (68)Ga Prostate-specific Membrane Antigen PET/MRI Compared with Multiparametric MRI for Detecting Clinically Significant Prostate Cancer.
    Radiology. 2021 Aug 31:204093. doi: 10.1148/radiol.2021204093.
    PubMed     Abstract available


    July 2021
  25. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
    Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
    Radiology. 2021 Jul 13:204321. doi: 10.1148/radiol.2021204321.
    PubMed     Abstract available


    May 2021
  26. DENIFFEL D, Healy GM, Dong X, Ghai S, et al
    Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.
    Radiology. 2021 May 25:204112. doi: 10.1148/radiol.2021204112.
    PubMed     Abstract available


  27. LI M, Guo J, Hu P, Jiang H, et al
    Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI.
    Radiology. 2021;299:E259.
    PubMed    


  28. GHAI S, Finelli A, Corr K, Chan R, et al
    MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Radiology. 2021;299:E258.
    PubMed    


  29. GOLDBERG SN
    More Interventional Oncologic Fire from COLDFIRE-2.
    Radiology. 2021;299:481-482.
    PubMed    


    April 2021
  30. HARMON SA, Gesztes W, Young D, Mehralivand S, et al
    Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.
    Radiology. 2021 Apr 13:202425. doi: 10.1148/radiol.2021202425.
    PubMed     Abstract available


  31. COSTA DN
    Multiparametric MRI of the Prostate: Beyond Cancer Detection and Staging.
    Radiology. 2021 Apr 13:204506. doi: 10.1148/radiol.2021204506.
    PubMed    


    March 2021
  32. JADVAR H
    Competitive Advantage of PSMA Theranostics in Prostate Cancer.
    Radiology. 2021 Mar 30:210348. doi: 10.1148/radiol.2021210348.
    PubMed    


  33. LAWHN-HEATH C, Salavati A, Behr SC, Rowe SP, et al
    Prostate-specific Membrane Antigen PET in Prostate Cancer.
    Radiology. 2021 Mar 30:202771. doi: 10.1148/radiol.2021202771.
    PubMed     Abstract available


  34. LI M, Guo J, Hu P, Jiang H, et al
    Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI.
    Radiology. 2021 Mar 9:201852. doi: 10.1148/radiol.2021201852.
    PubMed     Abstract available


    February 2021
  35. TEMPANY-AFDHAL CMC
    Focal Treatment of Prostate Cancer: MRI Helps Guide the Way Forward.
    Radiology. 2021 Feb 2:204333. doi: 10.1148/radiol.2021204333.
    PubMed    


  36. GHAI S, Finelli A, Corr K, Chan R, et al
    MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Radiology. 2021 Feb 2:202717. doi: 10.1148/radiol.2021202717.
    PubMed     Abstract available


  37. TEMPANY-AFDHAL CMC, Padhani A, Barentsz J, Weinreb J, et al
    Perspectives and Concerns about PI-RADS and Variability.
    Radiology. 2021;298:E112.
    PubMed    


    November 2020
  38. BAZARGANI S, Bandyk M, Balaji KC
    Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: What about the Negatives?
    Radiology. 2020 Nov 3:202870. doi: 10.1148/radiol.2020202870.
    PubMed    


    July 2020
  39. ZUKOTYNSKI KA, Rowe SP
    Histologic Validation of (18)F-DCFPyL PET/CT with Comparison to Multiparametric MRI in Biochemically Recurrent Prostate Cancer.
    Radiology. 2020 Jul 7:202098. doi: 10.1148/radiol.2020202098.
    PubMed    


  40. LINDENBERG L, Mena E, Turkbey B, Shih JH, et al
    Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of (18)F-DCFPyL PET/CT with Comparison to Multiparametric MRI.
    Radiology. 2020 Jul 7:192018. doi: 10.1148/radiol.2020192018.
    PubMed     Abstract available


  41. MILOT L
    Variation of PI-RADS Interpretations between Experts: A Significant Limitation.
    Radiology. 2020;296:85-86.
    PubMed    


    June 2020
  42. ZHANG Z, Wu HH, Priester A, Magyar C, et al
    Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology.
    Radiology. 2020 Jun 9:192330. doi: 10.1148/radiol.2020192330.
    PubMed     Abstract available


    May 2020
  43. TAN N, Oyoyo U, Bavadian N, Ferguson N, et al
    PSMA-targeted Radiotracers versus (18)F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis.
    Radiology. 2020 May 12:191689. doi: 10.1148/radiol.2020191689.
    PubMed     Abstract available


  44. PADHANI AR, Petralia G
    Radiologists Should Integrate Clinical Risk Factors with MRI Findings for Meaningful Prostate Cancer Staging.
    Radiology. 2020 May 5:201082. doi: 10.1148/radiol.2020201082.
    PubMed    


  45. PARK KJ, Kim MH, Kim JK
    Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy.
    Radiology. 2020 May 5:192133. doi: 10.1148/radiol.2020192133.
    PubMed     Abstract available


    April 2020
  46. WESTPHALEN AC, McCulloch CE, Anaokar JM, Arora S, et al
    Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.
    Radiology. 2020 Apr 21:190646. doi: 10.1148/radiol.2020190646.
    PubMed     Abstract available


  47. MEYRIGNAC O, Aziza R, Roumiguie M, Malavaud B, et al
    Closing the Gap between Prostate Cancer and Deep Learning Detection Tools.
    Radiology. 2020 Apr 14:200187. doi: 10.1148/radiol.2020200187.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: